Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMARCA2 | P51531 | 4/20 | 0.50 |
| ▸ | SMARCA4 | P51532 | 4/20 | 0.50 |
| ▸ | PBRM1 | Q86U86 | 4/20 | 0.50 |
| ▸ | TNF | P01375 | 1/20 | 0.37 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.37 |
| ▸ | NAMPT | P43490 | 1/20 | 0.36 |
| ▸ | TERT | O14746 | 1/20 | 0.36 |
| ▸ | BRD4 | O60885 | 3/20 | 0.36 |
| ▸ | IDO1 | P14902 | 1/20 | 0.34 |
| ▸ | RORC | P51449 | 1/20 | 0.34 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.34 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.34 |
| ▸ | OGFRL1 | Q5TC84 | 2/20 | 0.34 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.34 |
| ▸ | PIM1 | P11309 | 1/20 | 0.34 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.34 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.33 |
| ▸ | BACE1 | P56817 | 1/20 | 0.33 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.33 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26654173 | 0.86 | PBRM1 (0.38) | SMARCA2SMARCA4PBRM1BRD4 | |
| SCHEMBL30658036 | 0.81 | SSTR4 (0.39) | TNFSSTR4BRD4JAK3 | |
| SCHEMBL26801638 | 0.81 | SSTR4 (0.39) | TNFSSTR4BRD4JAK3 | |
| SCHEMBL30658035 | 0.80 | SMARCA2 (0.47) | SMARCA2SMARCA4PBRM1TNFNAMPT | |
| SCHEMBL26653853 | 0.80 | SMARCA2 (0.47) | SMARCA2SMARCA4PBRM1TNFNAMPT | |
| SCHEMBL26654087 | 0.80 | SMARCA2 (0.52) | SMARCA2SMARCA4PBRM1NAMPTTERT | |
| SCHEMBL26654108 | 0.78 | SMARCA2 (0.52) | SMARCA2SMARCA4PBRM1NAMPTTERT | |
| SCHEMBL30658054 | 0.78 | SMARCA2 (0.52) | SMARCA2SMARCA4PBRM1NAMPTTERT | |
| SCHEMBL30658005 | 0.78 | PBRM1 (0.38) | SMARCA2SMARCA4PBRM1BRD4 | |
| SCHEMBL26801645 | 0.78 | PBRM1 (0.38) | SMARCA2SMARCA4PBRM1BRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250302832-A1 | PYRAZINE DERIVATIVES AND USES THEREOF | FOGHORN THERAPEUTICS INC (US) | 2025-10-02 | — | — | US | disclosed |
| EP-4522279-A1 | PYRAZINE DERIVATIVES AND USES THEREOF | Foghorn Therapeutics Inc. (US) | 2025-03-19 | — | — | EP | disclosed |
| WO-2023220134-A1 | PYRAZINE DERIVATIVES AND USES THEREOF | FOGHORN THERAPEUTICS INC. (US) | 2023-11-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250302832-A1 | PYRAZINE DERIVATIVES AND USES THEREOF | BRCA1, VHL, SF3B5 | SMARCA2 77/4885SMARCA4 19/4885PBRM1 7/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.